4.1 Article

What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?

出版社

OXFORD UNIV PRESS
DOI: 10.1093/trstmh/traa193

关键词

COVID-19; ivermectin; mass drug administration; mathematical modelling; onchocerciasis; remedial strategies

资金

  1. Bill and Melinda Gates Foundation via the NTD Modelling Consortium [OPP1184344]
  2. UK Medical Research Council (MRC Doctoral Training Programme award)
  3. UK Department for International Development (DFID) Joint Centre under the MRC/DFID concordat agreement of the European Union
  4. European and Developing Countries Clinical Trials Partnership 2 [MR/R015600/1]
  5. MRC
  6. MRC [1975164] Funding Source: UKRI

向作者/读者索取更多资源

The mass drug administration of ivermectin for onchocerciasis has been disrupted by the COVID-19 pandemic. Mathematical modelling suggests that biannual treatments may be more effective in mitigating the impact of COVID-19 on MDA than simply increasing coverage. Programs with shorter treatment histories should prioritize remedial biannual MDA to prevent potential increases in microfilarial load with long-term health implications.
Background: Mass drug administration (MDA) of ivermectin for onchocerciasis has been disrupted by the coronavirus disease 2019 (COVID-19) pandemic. Mathematical modelling can help predict how missed/delayed MDA will affect short-term epidemiological trends and elimination prospects by 2030. Methods: Two onchocerciasis transmission models (EPIONCHO-IBM and ONCHOSIM) are used to simulate microfilarial prevalence trends, elimination probabilities and age profiles of Onchocerca volvulus microfilarial prevalence and intensity for different treatment histories and transmission settings, assuming no interruption, a 1-y (2020) interruption or a 2-y (2020-2021) interruption. Biannual MDA or increased coverage upon MDA resumption are investigated as remedial strategies. Results: Programmes with shorter MDA histories and settings with high pre-intervention endemicity will be the most affected. Biannual MDA is more effective than increasing coverage for mitigating COVID-19's impact on MDA. Programmes that had already switched to biannual MDA should be minimally affected. In high-transmission settings with short treatment history, a 2-y interruption could lead to increased microfilarial load in children (EPIONCHO-IBM) and adults (ONCHOSIM). Conclusions: Programmes with shorter (annual MDA) treatment histories should be prioritised for remedial biannual MDA. Increases in microfilarial load could have short- and long-termmorbidity andmortality repercussions. These results can guide decision-making to mitigate the impact of COVID-19 on onchocerciasis elimination.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据